Showing results (41-50 of 676) with videos related to

Sort By:
Pageof 68
Current Opinion in Neurology|April 2, 2016
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectivesOrhan Aktas, Philipp Albrecht, Hans-Peter Hartung
Neurology(R) Neuroimmunology & Neuroinflammation|March 3, 2021
Neuroprotective Properties of 4-AminopyridineMichael Dietrich, Hans-Peter Hartung, Philipp Albrecht
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 25, 2015
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisJens Ingwersen, Orhan Aktas, Hans-Peter Hartung
Trends in Pharmacological Sciences|October 27, 2015
PML: The Dark Side of Immunotherapy in Multiple SclerosisClemens Warnke, Tomas Olsson, Hans-Peter Hartung
Current Opinion in Neurology|April 9, 2016
Steering through complexity: management approaches in multiple sclerosisBruce A C Cree, Hans-Peter Hartung
Journal of Neurology|January 6, 2019
Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 studyHans-Peter Hartung, Jonas Graf, David Kremer
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 10, 2018
ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosisDavid Kremer, Patrick Küry, Hans-Peter Hartung
Plos One|September 7, 2012
Interferon gamma and sonic hedgehog signaling are required to dysregulate murine neural stem/precursor cellsJanine Walter, Hans-Peter Hartung, Marcel Dihné
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 2002
Natural recognition repertoire and the evolutionary emergence of the combinatorial immune systemJohn J Marchalonis, Srini Kaveri, Sébastien Lacroix-Desmazes, et al.
Journal of Vascular Research|December 15, 2006
Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cellsMathias Buttmann, Friederike Berberich-Siebelt, Edgar Serfling, et al.
Pageof 68